Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5589 ARTÍCULOS , VIENDO DEL 2146 AL 2160

Natural products attenuate PI3K/Akt/mTOR signaling pathway: A promising strategy in regulating neurodegeneration

Fakhri S, Iranpanah A, Gravandi MM, Moradi SZ, Ranjbari M, Majnooni MB, Echeverría J, Qi Y, Wang M, Liao P, Farzaei MH, Xiao J.

Phytomedicine. 2021 Oct;91:153664. doi: 10.1016/j.phymed.2021.153664. Epub 2021 Jul 25.

Dual-task intervention based on trail making test: Effects on Parkinson's disease

Silva RDN, Afonso SV, Felipe LR, Oliveira RA, Patrizzi Martins LJ, Pascucci Sande de Souza LA.

J Bodyw Mov Ther. 2021 Jul;27:628-633. doi: 10.1016/j.jbmt.2021.04.013. Epub 2021 May 4.

Gait and Balance Assessments using Smartphone Applications in Parkinson's Disease: A Systematic Review

Abou L, Peters J, Wong E, Akers R, Dossou MS, Sosnoff JJ, Rice LA.

J Med Syst. 2021 Aug 15;45(9):87. doi: 10.1007/s10916-021-01760-5.

Does Personality Change Follow Deep Brain Stimulation in Parkinson's Disease Patients?

Wilt JA, Merner AR, Zeigler J, Montpetite M, Kubu CS.

Front Psychol. 2021 Jul 30;12:643277. doi: 10.3389/fpsyg.2021.643277. eCollection 2021.

Redox Homeostasis and Prospects for Therapeutic Targeting in Neurodegenerative Disorders

Akanji MA, Rotimi DE, Elebiyo TC, Awakan OJ, Adeyemi OS.

Oxid Med Cell Longev. 2021 Aug 3;2021:9971885. doi: 10.1155/2021/9971885. eCollection 2021.

Hypoxia-Inducible Factor (HIF) in Ischemic Stroke and Neurodegenerative Disease

Mitroshina EV, Savyuk MO, Ponimaskin E, Vedunova MV.

Front Cell Dev Biol. 2021 Jul 28;9:703084. doi: 10.3389/fcell.2021.703084. eCollection 2021.

Insulin-degrading enzyme: an ally against metabolic and neurodegenerative diseases

Sousa L, Guarda M, Meneses MJ, Macedo MP, Vicente Miranda H.

J Pathol. 2021 Dec;255(4):346-361. doi: 10.1002/path.5777. Epub 2021 Sep 17.

Modelling the functional genomics of Parkinson's disease in Caenorhabditis elegans: LRRK2 and beyond

Chandler RJ, Cogo S, Lewis PA, Kevei E.

Biosci Rep. 2021 Sep 30;41(9):BSR20203672. doi: 10.1042/BSR20203672.

Ca(2+) handling at the mitochondria-ER contact sites in neurodegeneration

Lim D, Dematteis G, Tapella L, Genazzani AA, Calì T, Brini M, Verkhratsky A.

Cell Calcium. 2021 Sep;98:102453. doi: 10.1016/j.ceca.2021.102453. Epub 2021 Aug 5.

Does paraquat cause Parkinson's disease? A review of reviews

Weed DL.

Neurotoxicology. 2021 Sep;86:180-184. doi: 10.1016/j.neuro.2021.08.006. Epub 2021 Aug 13.

Advances in Genome-Scale Metabolic Modeling toward Microbial Community Analysis of the Human Microbiome

Esvap E, Ulgen KO.

ACS Synth Biol. 2021 Sep 17;10(9):2121-2137. doi: 10.1021/acssynbio.1c00140. Epub 2021 Aug 17.

Cancer risk in Parkinson disease: An updated systematic review and meta-analysis

Leong YQ, Lee SWH, Ng KY.

Eur J Neurol. 2021 Dec;28(12):4219-4237. doi: 10.1111/ene.15069. Epub 2021 Sep 12.

The Influence of Coronavirus Disease-2019 (COVID-19) On Parkinson's Disease: An Updated Systematic Review

Jaiswal V, Alquraish D, Sarfraz Z, Sarfraz A, Nagpal S, Singh Shrestha P, Mukherjee D, Guntipalli P, Sánchez Velazco DF, Bhatnagar A, Savani S, Halilaj E, Ruxmohan S, Cueva W.

J Prim Care Community Health. 2021 Jan-Dec;12:21501327211039709. doi: 10.1177/21501327211039709.

Evaluating pimavanserin as a treatment for psychiatric disorders: A pharmacological property in search of an indication

Davis J, Zamora D, Horowitz M, Leucht S.

Expert Opin Pharmacother. 2021 Sep;22(13):1651-1660. doi: 10.1080/14656566.2021.1942455. Epub 2021 Aug 18.

Impulse Control Disorders in Parkinson's Disease: Has COVID-19 Related Lockdown Been a Trigger?

Rábano-Suárez P, Martínez-Fernández R, Natera-Villalba E, Pareés I, Martínez-Castrillo JC, Alonso-Canovas A.

Mov Disord Clin Pract. 2021 Jul 9;8(6):940-943. doi: 10.1002/mdc3.13276. eCollection 2021 Aug.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias